Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 207

1.

CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus.

Shi XY, Bhagwandeen B, Leong AS.

Am J Clin Pathol. 2008 Apr;129(4):571-7. doi: 10.1309/UWK3NAHV31GFHM3J.

PMID:
18343784
[PubMed - indexed for MEDLINE]
Free Article
2.

CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.

Weimann A, Zimmermann M, Gross M, Slevogt H, Rieger A, Morawietz L.

Int J Surg Pathol. 2010 Oct;18(5):330-7. doi: 10.1177/1066896910364228. Epub 2010 May 5.

PMID:
20444732
[PubMed - indexed for MEDLINE]
3.

Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.

Xiao ZY, Ru Y, Sun JT, Gao SG, Wang YF, Wang LD, Feng XS.

Asian Pac J Cancer Prev. 2012;13(1):247-50.

PMID:
22502678
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.

Phillips RW, Frierson HF Jr, Moskaluk CA.

Am J Surg Pathol. 2003 Nov;27(11):1442-7.

PMID:
14576477
[PubMed - indexed for MEDLINE]
6.

Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.

Regalado SP, Nambu Y, Iannettoni MD, Orringer MB, Beer DG.

Mol Carcinog. 1998 Jul;22(3):182-9.

PMID:
9688144
[PubMed - indexed for MEDLINE]
7.

Foveolar type dysplasia in Barrett esophagus.

Brown IS, Whiteman DC, Lauwers GY.

Mod Pathol. 2010 Jun;23(6):834-43. doi: 10.1038/modpathol.2010.59. Epub 2010 Mar 12.

PMID:
20228780
[PubMed - indexed for MEDLINE]
Free Article
8.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
[PubMed - indexed for MEDLINE]
9.

Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.

Groisman GM, Amar M, Meir A.

Mod Pathol. 2004 Oct;17(10):1282-8.

PMID:
15167938
[PubMed - indexed for MEDLINE]
Free Article
10.

COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.

Villanacci V, Rossi E, Zambelli C, Galletti A, Cestari R, Missale G, Casa DD, Bassotti G.

Dig Liver Dis. 2007 Apr;39(4):305-11. Epub 2007 Feb 16.

PMID:
17307036
[PubMed - indexed for MEDLINE]
11.

Hepatocyte antigen as a marker of intestinal metaplasia.

Chu PG, Jiang Z, Weiss LM.

Am J Surg Pathol. 2003 Jul;27(7):952-9.

PMID:
12826887
[PubMed - indexed for MEDLINE]
12.

An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.

Lu D, Vohra P, Chu PG, Woda B, Rock KL, Jiang Z.

Am J Surg Pathol. 2009 Apr;33(4):521-5. doi: 10.1097/PAS.0b013e31818aada9.

PMID:
19047899
[PubMed - indexed for MEDLINE]
13.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
[PubMed - indexed for MEDLINE]
14.

Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.

Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P.

Histol Histopathol. 2002 Apr;17(2):445-54.

PMID:
11962749
[PubMed - indexed for MEDLINE]
15.

Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study.

Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK.

Ann Surg. 1997 Dec;226(6):725-33; discussion 733-5.

PMID:
9409571
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy.

Bax D, Siersema PD, Moons LM, Dekken Hv, Tilanus HW, Kusters JG, Kuipers EJ.

J Clin Gastroenterol. 2007 Apr;41(4):375-9.

PMID:
17413605
[PubMed - indexed for MEDLINE]
17.

Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry.

Sarbia M, Donner A, Franke C, Gabbert HE.

Hum Pathol. 2004 Mar;35(3):371-6.

PMID:
15017595
[PubMed - indexed for MEDLINE]
18.

Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?

Kerkhof M, Bax DA, Moons LM, van Vuuren AJ, van Dekken H, Steyerberg EW, Kuipers EJ, Kusters JG, Siersema PD; Cybar Study Group.

Aliment Pharmacol Ther. 2006 Dec;24(11-12):1613-21.

PMID:
17206949
[PubMed - indexed for MEDLINE]
Free Article
19.

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?

Khor TS, Alfaro EE, Ooi EM, Li Y, Srivastava A, Fujita H, Park Y, Kumarasinghe MP, Lauwers GY.

Am J Surg Pathol. 2012 Mar;36(3):331-42. doi: 10.1097/PAS.0b013e31823d08d6.

PMID:
22261707
[PubMed - indexed for MEDLINE]
20.

Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.

Shaheen NJ, Spechler SJ.

Endoscopy. 2008 Dec;40(12):994-9. doi: 10.1055/s-2008-1077785. Epub 2008 Dec 8. Review. No abstract available.

PMID:
19065482
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk